Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

University of Oxford researchers from the Department of Physiology, Anatomy and Genetics (DPAG) and the Department of Psychiatry, in collaboration with The 1928 Institute, have published a major new study on the impact of COVID-19 on the UK’s largest BME population.

A medical professional wearing a mask and safety gloves prepares COVID-19 Vaccine

The new study has shed light on the willingness of British Indians to take a COVID-19 vaccine (56%) and the impact of the pandemic on the health and culture of the Indian diaspora in the UK. 

The 1928 Institute, a think tank co-founded by Dr Nikita Ved, Department of Physiology, Anatomy and Genetics (DPAG), and Kiran Kaur Manku, Department of Psychiatry, are working together to research and represent the views of British Indians – the UK’s largest ethnic minority group. 

Researchers have been working on two projects with the University of Oxford: The British Indian Census; a seminal piece of work for the British Indian community, and Pulse & Policy; short, topical surveys designed to poll the community on timely and pressing issues.  

This new COVID-19 report is a culmination of all COVID-19 related data from these projects, findings include: 

  • Only 56% of British Indians would take a COVID-19 vaccine when offered, which is significantly lower than the national average of 79%
  • Women are significantly less likely than men to take a vaccine with 52% of women willing to take the vaccine, compared with 63% of men. 
  • 19% of British Indians feel that other people should have priority in receiving a vaccine, specifically those who are vulnerable and those in Low- and Middle-Income Countries.
  • 75% of British Indians face barriers in accessing mental healthcare, and men in particular have overwhelming concerns of suicide. 

The full story is available on the Department of Physiology, Anatomy & Genetics website, and also the Department of Psychiatry website.

Similar stories

PRINCIPLE Covid-19 treatments trial widens to under 50s and adds colchicine

Clinical Trials Coronavirus COVID-19 General Research

From today, the UK’s national priority platform trial of Covid-19 treatments for recovery at home launches its investigation of the gout drug colchicine, and expands for the first time to include adults of any age.

Regular meat consumption linked with a wide range of common diseases

Research

Regular meat consumption is associated with a range of diseases that researchers had not previously considered, according to a large, population-level study conducted by a team at the University of Oxford.

New data show vaccines reduce severe COVID-19 in older adults

Coronavirus COVID-19 Research

New data show both Oxford / AstraZeneca vaccine and the Pfizer-BioNTech vaccines significantly reduce severe COVID-19 in older adults.

Singula Bio, a new Oxford spin-out company - Cancer need not be fatal

General Innovation Research

Singula Bio, a bold new seed-stage biotechnology company spun out of Oxford University, has been launched with the intention of helping show that cancer need not be fatal. Led by three Oxford cancer specialists, the firm is aims to become a world leader in therapies to use against difficult-to-treat solid malignancies such as ovarian cancer - using the body’s own immune system to fight previously fatal cancers.

Major rise in public support for COVID vaccine – Oxford study

Coronavirus COVID-19 General Research

More than three quarters of people in the UK now say they are ’very likely’ to have the vaccine – up from 50% among the same group of survey respondents five months ago –according to a two-wave Oxford University survey published today.